Concourse Financial Group Securities’s NeuroSense Therapeutics NRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Hold
0
5487
2024
Q4
Hold
0
6351
2024
Q3
Hold
0
6345
2024
Q2
Hold
0
6364
2024
Q1
Hold
0
6361
2023
Q4
Hold
0
6292
2023
Q3
Hold
0
6157
2023
Q2
Hold
0
6012
2023
Q1
Hold
0
5795
2022
Q4
Hold
0
5791
2022
Q3
Hold
0
5612
2022
Q2
Hold
0
5589
2022
Q1
Hold
0
5484
2021
Q4
Hold
0
5489